Literature DB >> 22521545

Breast cancer, side population cells and ABCG2 expression.

K M Britton1, R Eyre2, I J Harvey1, K Stemke-Hale3, D Browell4, T W J Lennard5, A P Meeson6.   

Abstract

Recurrent metastatic breast cancer may arise in part due to the presence of drug resistant adult stem cells such as Side Population (SP) cells, whose phenotype has been demonstrated to be due to the expression of ABCG2. We hypothesised that SP may be identified in Fine Needle Aspirates (FNAs) and their presence may be determined by expression of ABCG2 in breast tumours. SP and non-side population cells (NSP) were isolated using dual wavelength flow cytometry combined with Hoechst 33342 dye efflux and analysed for expression of ABCG2 and chemoresistance. FNA samples used in SP analysis were matched with paraffin-embedded tissue which was used in immunohistochemical analysis to assess ABCG2 expression. Results were correlated to the pathobiology of the tumour. MCF7 and MDA-MB-231 cell lines contain SP cells. MCF7 SP have increased expression of ABCG2 and increased resistance to mitoxantrone compared to NSP cells. The presence of SP in FNAs were significantly associated with ER-negative (p=0.008) and with triple negative breast cancers (p=0.011) which were also found to have a significant increase in ABCG2 protein expression. ABCG2 transcript was detected in some but not all SP cell populations isolated from FNA samples.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521545      PMCID: PMC3880937          DOI: 10.1016/j.canlet.2012.03.041

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice.

Authors:  Johan W Jonker; Jamie Freeman; Ellen Bolscher; Sandra Musters; Azra J Alvi; Ian Titley; Alfred H Schinkel; Trevor C Dale
Journal:  Stem Cells       Date:  2005-07-07       Impact factor: 6.277

2.  Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.

Authors:  Sophie Vibet; Karine Mahéo; Jacques Goré; Pierre Dubois; Philippe Bougnoux; Igor Chourpa
Journal:  Drug Metab Dispos       Date:  2007-02-12       Impact factor: 3.922

3.  Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.

Authors:  Paul P Szotek; Rafael Pieretti-Vanmarcke; Peter T Masiakos; Daniela M Dinulescu; Denise Connolly; Rosemary Foster; David Dombkowski; Frederic Preffer; David T Maclaughlin; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-18       Impact factor: 11.205

4.  Side population cells isolated from mesenchymal neoplasms have tumor initiating potential.

Authors:  Colleen Wu; Qingxia Wei; Velani Utomo; Puviindran Nadesan; Heather Whetstone; Rita Kandel; Jay S Wunder; Benjamin A Alman
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

5.  Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele.

Authors:  Mehrdad Tadjali; Sheng Zhou; Jerold Rehg; Brian P Sorrentino
Journal:  Stem Cells       Date:  2006-02-16       Impact factor: 6.277

6.  Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.

Authors:  Jiangbing Zhou; Julia Wulfkuhle; Hao Zhang; Peihua Gu; Yanqin Yang; Jianghong Deng; Joseph B Margolick; Lance A Liotta; Emanuel Petricoin; Ying Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

7.  Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.

Authors:  Matthias Christgen; Matthias Ballmaier; Henriette Bruchhardt; Reinhard von Wasielewski; Hans Kreipe; Ulrich Lehmann
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

Review 8.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

9.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.

Authors:  Jing Wang; Li-Ping Guo; Li-Zhen Chen; Yi-Xin Zeng; Shih Hsin Lu
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

View more
  46 in total

1.  Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.

Authors:  Ji Na Kong; Qian He; Guanghu Wang; Somsankar Dasgupta; Michael B Dinkins; Gu Zhu; Austin Kim; Stefka Spassieva; Erhard Bieberich
Journal:  Int J Cancer       Date:  2015-04-27       Impact factor: 7.396

Review 2.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

Review 3.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 4.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 5.  Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?

Authors:  Hidetaka Shima; Akimitsu Yamada; Takashi Ishikawa; Itaru Endo
Journal:  Gland Surg       Date:  2017-02

6.  A role for ABCG2 beyond drug transport: Regulation of autophagy.

Authors:  Rui Ding; Shengkan Jin; Kirk Pabon; Kathleen W Scotto
Journal:  Autophagy       Date:  2016-05-03       Impact factor: 16.016

7.  Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma.

Authors:  Guo-Fang Guan; DE-Jun Zhang; Ying Zheng; Lian-Ji Wen; Duo-Jiao Yu; Yan-Qing Lu; Yan Zhao
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

8.  Isolation of side population cells from endometrial cancer cells using a violet laser diode.

Authors:  Satoshi Tomiyasu; Tomoyuki Miyamoto; Michihiro Mori; Takahiro Yaguchi; Hiromasa Yakushiji; Setsuyo Ohno; Yasuyuki Miyake; Takuya Sakaguchi; Masatsugu Ueda; Eiji Ohno
Journal:  Hum Cell       Date:  2013-10-04       Impact factor: 4.174

Review 9.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.

Authors:  Giampaolo Bianchini; Justin M Balko; Ingrid A Mayer; Melinda E Sanders; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2016-05-17       Impact factor: 66.675

Review 10.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.